Luminary Therapeutics
Minneapolis, MN · Biotechnology · 10 employees
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We h
Funding history
- Venture - Series Unknown — $1.4M — Nov 2025
- Venture - Series Unknown — $5.2M — Jan 2025
- Venture - Series Unknown — $5.2M — Jan 2025
- Seed — $2.4M — Aug 2023
- Seed — $2.2M — Jan 2023
Recent signals
- Nov 05, 2025: Raised $1.4M in Venture - Series Unknown
- Jan 08, 2025: Raised $5.2M in Venture - Series Unknown
- Jan 08, 2025: Raised $5.2M in Venture - Series Unknown
- Aug 03, 2023: Raised $2.4M in Seed
- Jan 11, 2023: Raised $2.2M in Seed
- Nov 04, 2021: Raised $375K in Venture - Series Unknown
- Feb 09, 2021: Raised $825K in Venture - Series Unknown
- Nov 14, 2019: Raised $5.2M in Venture - Series Unknown
See plans & pricing → Track Luminary Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.